THEME 9 IN VITRO EXPERIMENTAL MODELS

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

• Publication date

  2014-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3109/21678421.2014.960186PMID 25382839
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis

  2014cited by this paper
• Superoxide dismutase 1 mutation in a cellular model of amyotrophic lateral sclerosis shifts energy generation from oxidative phosphorylation to glycolysis.

  2014cited by this paper
• Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis.

  2013cited by this paper
• A small molecule screen in stem-cell-derived motor neurons identifies a kinase inhibitor as a candidate therapeutic for ALS.

  2013cited by this paper
• Therapeutic Potential of Mesenchymal Stromal Cells and MSC Conditioned Medium in Amyotrophic Lateral Sclerosis (ALS) - In Vitro Evidence from Primary Motor Neuron Cultures, NSC-34 Cells, Astrocytes and Microglia

  2013cited by this paper
• The Non-Protein Amino Acid BMAA Is Misincorporated into Human Proteins in Place of l-Serine Causing Protein Misfolding and Aggregation

  2013cited by this paper
• Creating a neural specific chromatin landscape by npBAF and nBAF complexes.

  2013cited by this paper
• Exome sequencing to identify de novo mutations in sporadic ALS trios

  2013cited by this paper
• Targeting RNA Foci in iPSC-Derived Motor Neurons from ALS Patients with a C9ORF72 Repeat Expansion

  2013cited by this paper
• Stress granules as crucibles of ALS pathogenesis

  2013cited by this paper
• Expanded GGGGCC repeat RNA associated with amyotrophic lateral sclerosis and frontotemporal dementia causes neurodegeneration

  2013cited by this paper
• Intravenous Mesenchymal Stem Cells Improve Survival and Motor Function in Experimental Amyotrophic Lateral Sclerosis

  2012cited by this paper
• Mutations in the Profilin 1 Gene Cause Familial Amyotrophic Lateral Sclerosis

  2012cited by this paper
• Amyotrophic lateral sclerosis-associated mutant VAPBP56S perturbs calcium homeostasis to disrupt axonal transport of mitochondria

  2012cited by this paper
• The unfolded protein response in models of human mutant G93A amyotrophic lateral sclerosis

  2012cited by this paper
• A greatly extended PPARGC1A genomic locus encodes several new brain-specific isoforms and influences Huntington disease age of onset.

  2012cited by this paper
• Gene expression profiling in human neurodegenerative disease

  2012cited by this paper
• Efficient Reprogramming of Human Cord Blood CD34+ Cells Into Induced Pluripotent Stem Cells With OCT4 and SOX2 Alone.

  2012cited by this paper
• Efficient reprogramming of human cord blood CD34+ cells into induced pluripotent stem cells with OCT4 and SOX2 alone.

  2012cited by this paper
• Compartmentalization of superoxide dismutase 1 (SOD1G93A) aggregates determines their toxicity

  2012cited by this paper
• RNA-binding proteins with prion-like domains in ALS and FTLD-U

  2011cited by this paper
• Misfolded superoxide dismutase‐1 in CSF from amyotrophic lateral sclerosis patients

  2011cited by this paper
• Firefly luciferase mutants as sensors of proteome stress

  2011cited by this paper
• Energy metabolism in amyotrophic lateral sclerosis.

  2011cited by this paper
• A Burkholderia pseudomallei Toxin Inhibits Helicase Activity of Translation Factor eIF4A

  2011cited by this paper
• Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis

  2011cited by this paper
• PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility.

  2011cited by this paper
• Stress signaling from the endoplasmic reticulum: A central player in the pathogenesis of amyotrophic lateral sclerosis

  2011cited by this paper
• Abnormal exocytotic release of glutamate in a mouse model of amyotrophic lateral sclerosis

  2011cited by this paper
• ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS/TLS

  2010cited by this paper
• Inhibition of Eukaryotic Translation Elongation by Cycloheximide and Lactimidomycin

  2010cited by this paper
• 1H-NMR-Based Metabolomic Profiling of CSF in Early Amyotrophic Lateral Sclerosis

  2010cited by this paper
• Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules.

  2010cited by this paper
• In vitro activation of GAT1 transporters expressed in spinal cord gliosomes stimulates glutamate release that is abnormally elevated in the SOD1/G93A(+) mouse model of amyotrophic lateral sclerosis

  2010cited by this paper
• The mechanism of Ca2+ -dependent regulation of kinesin-mediated mitochondrial motility.

  2009cited by this paper
• X-ray structure of Pur-α reveals a Whirly-like fold and an unusual nucleic-acid binding surface

  2009cited by this paper
• Miro1 Is a Calcium Sensor for Glutamate Receptor-Dependent Localization of Mitochondria at Synapses

  2009cited by this paper
• Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6

  2009cited by this paper
• Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis

  2009cited by this paper
• Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria content.

  2007cited by this paper
• Pathological TDP‐43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations

  2007cited by this paper
• Axonal transport of mitochondria requires milton to recruit kinesin heavy chain and is light chain independent

  2006cited by this paper
• GRIF-1 and OIP106, Members of a Novel Gene Family of Coiled-Coil Domain Proteins

  2005cited by this paper
• An integrative approach to gain insights into the cellular function of human ataxin-2.

  2005cited by this paper
• Glutamate receptors: RNA editing and death of motor neurons

  2004cited by this paper
• Excessive and precocious glutamate release in a mouse model of amyotrophic lateral sclerosis.

  2004cited by this paper
• Modulation of recombinant and native neuronal SK channels by the neuroprotective drug riluzole.

  2002cited by this paper
• Riluzole inhibits the persistent sodium current in mammalian CNS neurons

  2000cited by this paper
• The pharmacology and mechanism of action of riluzole

  1996cited by this paper
• Riluzole inhibits the release of glutamate in the caudate nucleus of the cat in vivo.

  1992cited by this paper
• Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis

  1990cited by this paper
• Atrophic Cell Processes of Large Motor Neurons in the Anterior Horn in Amyotrophic Lateral Sclerosis: Observation with Silver Impregnation Method

  1987cited by this paper

• No citing papers are available for this paper.